首页 | 本学科首页   官方微博 | 高级检索  
     


Bulking agents: a urogynecology perspective
Authors:Dani Zoorob  Mickey Karram
Affiliation:a Department of Obstetrics and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery, The Christ Hospital/University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267, USA
b The Christ Hospital, 2123 Auburn Avenue, Suite 307, Cincinnati, OH 45219, USA
Abstract:A bulking agent is a material injected into the wall of the urethra to improve urethral coaptation in women suffering from stress incontinence. The concept was initially described in the 1930s when sodium morrhuate and paraffin were used to augment urethral resistance. Sclerosing agents were also used for inducing permanent urethral scaring to improve urinary leakage. Eventually, collagen and autologous fat were found to be efficacious, and only collagen demonstrated proven safety and endured extensive testing, becoming the gold standard for injectable agents. Since then, multiple other products have been developed by the industry, each with its particular success rates and complications.
Keywords:Bulking agent   Contigen   Durasphere   Coaptite   Bulkamid
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号